argenx Bets $2.2 Billion on a Vitiligo Breakthrough: What the Forte Biosciences Deal Means for Both Stocks
The biopharma sector is in the middle of a transformation in which macroeconomic pressures and policy developments actively dictate corporate dealmaking. As leading pharmaceutical companies prepare fo
Yahoo Finance — 29 July 2026
Text:
28
0
0
The biopharma sector is in the middle of a transformation in which macroeconomic pressures and policy developments actively dictate corporate dealmaki
Read Full Story at Yahoo Finance → Sources
📈 Markets & Finance
Little Movement Seen For Thai Stock Market
📈 Markets & Finance
Trump finalizes new tariffs on dozens of countries
📈 Markets & Finance
Where Will Solana Be in 3 Years?
📈 Markets & Finance
Ethereum Foundation adds SEAL 911 co-founder to board as privacy focus grows
📈 Markets & Finance
American Airlines Cut Its Full-Year Guidance. The Stock Rose 6.8% the Next Day.
📈 Markets & Finance
Sophie Cunningham shares special moment with Brittney Griner before Fever-Sun game
